Inhibition of adjuvant arthritis by statolon.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to M A Kapusta.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
This study confirms observations that active adjuvant-induced disease is accompanied by diminished spleen cell responses to phytohemagglutinin and concanavalin A; and that these diminished responses are due to suppressor cells, some adherent only to glass, and others adherent to plastic or glass. Corticosteroid inhibition of adjuvant disease is accompanied by a diminution or absence of these splenic suppressor cells. Some of these suppressor cells are inhibited in vitro by corticosteroids, in preference to the mitogen-responsive cells. This suggests that suppressor cells may play a role in the pathogenesis of AID.
I suggest that many of the features of the autoimmune diseases may be explained by an alteration in the immunoregulatory balance of various T lymphocyte populations by virus-activated suppressor cells. The evidence for this hypothesis is presented and evaluated in adjuvant disease in rats, NZB/W disease in mice, and in human autoimmune diseases.
Relapsing polychondritis, a rare disorder characterized by inflammation of cartilaginous tissue, is often associated with vasculitic features. Wegener's granulomatosis is an uncommon form of vasculitis, usually responsive to treatment with cyclophosphamide. A 59-yr-old man with relapsing polychondritis, initially well controlled by corticosteroid therapy, developed pulmonary infiltrates and glomerulonephritis. After pathological confirmation of Wegener's granulomatosis, cyclophosphamide therapy was instituted and remission achieved.